Home / Guides / Mounjaro Patient Assistance Program Guide
PT
PharmTeam Editorial Updated October 15, 2026

Mounjaro Patient Assistance Program Guide

If you are exploring Mounjaro patient assistance program, this comprehensive resource breaks down the latest evidence, practical tips, and expert insights to help you make informed decisions about your health journey.

Available Savings Programs

Numerous savings programs exist for GLP-1 buyers:

  • Manufacturer savings cards: Drug makers offer copay savings that bring down your cost to as low as $25.
  • Patient assistance programs (PAPs): Zero-cost drugs for qualifying uninsured.
  • Discount cards: RxSaver offer discounts at participating pharmacies.
  • Copay assistance: Charitable programs from patient advocacy groups that help cover medication costs.

Application Process

  1. Go to the manufacturer’s assistance page (the drug maker’s portal)
  2. Check your enrollment criteria
  3. Enroll through the portal or by phone
  4. Present your savings code at the pharmacy at pickup

Qualification Criteria

Nearly all manufacturer savings programs need:

  • Employer-sponsored insurance (not Medicare/Medicaid)
  • Existing prescription from a board-certified prescriber
  • US residency
  • At least 18 years old

Frequently Asked Questions

How do I get the Ozempic savings card?

Check NovoCare.com, check your eligibility, and register online. Those who qualify might pay as little as $25 per month.

Can I use GoodRx for Mounjaro?

Yes. GoodRx offers savings for Mounjaro at participating pharmacies. Savings differ by store.

Frequently Asked Questions

Where can I find further reading on Mounjaro patient assistance program?

Reliable sources include peer-reviewed medical journals including the Mayo Clinic and the Endocrine Society. Always verify information with a medical professional.

What should I ask my doctor about Mounjaro patient assistance program?

Open with bringing up how this applies to your specific situation. Your doctor can customize guidance based on your health history and other treatments you are taking.

More Information

Is Mounjaro patient assistance program suitable for ongoing use?

Ongoing treatment safety evidence for GLP-1 drugs continues to grow as new clinical trials becomes available. Existing research suggests that in the majority of cases, long-term treatment with proper monitoring can be maintained. Periodic evaluations are critical to treatment remains appropriate as treatment progresses.